Clinical suppression of precocious puberty with cetrorelix after failed treatment with GnRH agoinst in a girl with gonadotrophin-independent precocious puberty

Reproductive BioMedicine Online

Volumn 11, Issue 1, 2005, Pages 18-21

  Wu, Meng Hsing ^a   Lin, Shio Jean ^b   Wu, Li Hsiang ^a   Cheng, Yueh Chin ^a   Chou, Yen Yin ^b   Pan, Hsien An ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

GnRH agonist; GnRH antagonist; Precocious puberty

Indexed keywords

CETRORELIX; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE;

ARTICLE; BODY HEIGHT; BODY WEIGHT; CASE REPORT; CHILD GROWTH; CLINICAL OBSERVATION; ECHOGRAPHY; ENDOCRINOLOGY; FEMALE; GROWTH ACCELERATION; HUMAN; MORPHOLOGY; OUTPATIENT DEPARTMENT; OVARY; OVULATION; PRECOCIOUS PUBERTY; PREPUBERTY; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME; UTERUS; VAGINA BLEEDING;

EID: 21844457888     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61293-X     Document Type: Article

References (10)

1. Buzi F, Pilotta A, Dordoni D et al. 1998 Pelvic ultrasonography in normal girls and in girls with pubertal precocity. Acta Paediatrica 87, 1138-1145.
2. Garcia-Velasco, JA, Isaza, V, Vidal C et al. 2001 Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix). Human Reproduction 16, 2533-2539.
3. Gonzalez-Bulnes A, Lopez-Sebastian A, Garcia-Garcia RM et al. 2005 Restoration of endocrine and ovarian function after stopping GnRH antagonist treatment in goats. Theriogenology 63, 83-91.
4. Ortmarm O, Weiss JM, Diedrich K 2001 Embryo implantation and GnRH antagonists: ovarian actions of GnRH antagonists. Human Reproduction 16, 608-611.
5. Roth C 2002 Therapeutic potential of GnRH antagonists in the treatment of precocious puberty. Expert Opinion on Investigational Drugs 119, 1253-1259.
6. Roth C, Leonhardt S, Seidel C et al. 2000 Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model. Pediatric Research 48, 468-474.
7. Roth C, Schricker M, Lakomek M et al. 2001 Autoregulation of the gonadotrophin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model. Journal of Endocrinology 169, 361-371.
8. Roth C, Hegemann F, Hildebrandt J et al. 2004 Pituitary and gonadal effects of GnRH (gonadotrophin releasing hormone) analogues in two peripubertal female rat models. Pediatric Research 55, 126-133.
9. Salardi S, Orsini LF, Cacciari E et al. 1985 Pelvic ultrasonography in premenarcheal girls: relation to puberty and sex hormone concentrations. Archives of Disease in Childhood 60, 120-125.
10. Tur-Kaspa I, Zohav E, Segal O et al. 2001 Three-dimensional endometrial and uterine volumes changes during induction of ovulation for IVF-GnRH antagonist versus GnRH agonist protocols. Fertility and Sterility 76 (suppl. 1), S24.